Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TALIMOGENE LAHERPAREPVEC Cause Pyrexia? 135 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Pyrexia have been filed in association with TALIMOGENE LAHERPAREPVEC (Imlygic). This represents 9.2% of all adverse event reports for TALIMOGENE LAHERPAREPVEC.

135
Reports of Pyrexia with TALIMOGENE LAHERPAREPVEC
9.2%
of all TALIMOGENE LAHERPAREPVEC reports
9
Deaths
38
Hospitalizations

How Dangerous Is Pyrexia From TALIMOGENE LAHERPAREPVEC?

Of the 135 reports, 9 (6.7%) resulted in death, 38 (28.1%) required hospitalization, and 3 (2.2%) were considered life-threatening.

Is Pyrexia Listed in the Official Label?

Yes, Pyrexia is listed as a known adverse reaction in the official FDA drug label for TALIMOGENE LAHERPAREPVEC.

What Other Side Effects Does TALIMOGENE LAHERPAREPVEC Cause?

Off label use (196) Product storage error (133) Metastatic malignant melanoma (109) Circumstance or information capable of leading to medication error (89) Death (82) Influenza like illness (82) Fatigue (70) Chills (68) Malignant melanoma (64) Therapy partial responder (56)

What Other Drugs Cause Pyrexia?

ADALIMUMAB (12,160) METHOTREXATE (10,158) RITUXIMAB (10,061) PREDNISONE (8,141) ETANERCEPT (7,626) INFLIXIMAB (6,560) ACETAMINOPHEN (6,414) CYCLOPHOSPHAMIDE (6,126) TOCILIZUMAB (5,529) LENALIDOMIDE (5,496)

Which TALIMOGENE LAHERPAREPVEC Alternatives Have Lower Pyrexia Risk?

TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB-TGVS TALIMOGENE LAHERPAREPVEC vs TAMIFLU TALIMOGENE LAHERPAREPVEC vs TAMOXIFEN TALIMOGENE LAHERPAREPVEC vs TAMSULOSIN

Related Pages

TALIMOGENE LAHERPAREPVEC Full Profile All Pyrexia Reports All Drugs Causing Pyrexia TALIMOGENE LAHERPAREPVEC Demographics